Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AVADEL PHARMACEUTICALS PLC (AVDL)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Total revenues  1.50.00.00.00.00.00.00.0
            Revenue growth        -100.0%-100.0%
Cost of goods sold  0.00.00.00.00.10.00.00.0
Gross profit  1.50.00.00.0-0.10.00.00.0
            Gross margin  97.6%       
Selling, general and administrative   [+]46.814.121.821.621.021.315.211.0
Research and development  4.22.94.57.02.14.46.83.9
Other operating expenses      -0.1   
EBITDA   [+] -16.6-26.1-28.4-22.9-25.5-21.7-14.6
            EBITDA margin  -3311.6%       
Depreciation and amortization   0.40.20.30.20.20.20.2
EBIT   [+]-49.5-17.0-26.3-28.6-23.1-25.7-21.9-14.9
            EBIT margin  -3311.6%       
Non-recurring items   -0.13.6 0.1  -0.1
Interest expense, net   [+]1.73.13.31.93.61.41.51.3
Other income (expense), net   [+]-13.1  -0.211.5 0.10.1
Pre-tax income  -64.3-20.1-33.3-30.7-15.2-27.1-23.3-16.1
Income taxes  0.10.130.2-4.3-4.3-5.1-3.8-2.6
            Tax rate     14.1%28.6%18.8%16.1%16.2%
Net income  -64.4-20.1-63.4-26.4-10.8-22.0-19.6-13.4
            Net margin  -4307.0%       
   
Basic EPS   [+]($0.83)($0.33)($1.07)($0.45)($0.18)($0.38)($0.33)($0.23)
Diluted EPS   [+]($0.83)($0.33)($1.07)($0.45)($0.18)($0.38)($0.33)($0.23)
   
Shares outstanding (basic)   [+]77.260.259.058.858.558.658.558.4
Shares outstanding (diluted)   [+]77.260.259.058.858.558.658.558.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy